CTI first quarter net loss decreases 66 percent to $17.

CTI first quarter net loss decreases 66 percent to $17.4 million Cell Therapeutics, Inc. today reported financial results and recent accomplishments for the first quarter of 2012 safety pharmacology http://propeciasverige.com . First Quarter Financial Results For the one fourth ended March 31, 2012, total operating expenses were $18.1 million in comparison to $20.1 million for the same period in 2011. Net loss attributable to common shareholders reduced 66 percent to $17.4 million for the quarter ended March 31, 2012 in comparison to a net loss attributable to common shareholders of $51.0 million for the same period in 2011.